Key result
Compared with young persons, P-selectin-exposing platelet microparticles were increased in older persons (P=0.02) and further increased in patients with NSTEMI (P=0.007) and STEMI (P=0.045).
Observational (n=61)
PMP subpopulations exposing P-selectin and CD63 reflect platelet activation status better than total PMP numbers and are elevated in aging, peripheral arterial disease, and myocardial infarction.
Supports specific PMP subpopulations as platelet activation markers in CVD; confirms in vitro patterns in patients with stable angina, PAD, and MI.
BACKGROUND: Platelet-derived microparticles (PMPs) are generally considered a marker of platelet activation in cardiovascular disease. We studied the extent to which PMP subpopulations parallel platelet activation in vitro and in vivo. METHODS: Using flow cytometry, we analyzed PMP subpopulations from resting and activated platelets in vitro (n = 6) as well as from plasma samples of patients with stable angina, peripheral arterial disease, or myocardial infarction [non-ST-elevation (NSTEMI) and ST-elevation (STEMI)] and from older, age- and sex-matched and young healthy individuals [n = 10 for all groups except NSTEMI (n = 11)]. Coagulation markers prothrombin fragment F(1 + 2) and thrombin-antithrombin complexes were determined by ELISA. The PMP-associated fraction of soluble (s)P-selectin was estimated by ELISA. RESULTS: In vitro, stimulation of platelets with thrombin receptor-activating peptide (15 micromol/L) or the calcium ionophore A23187 (2.5 micromol/L) increased fractions of both platelets and PMPs exposing P-selectin or CD63 (P <0.001 for all). Whereas the number of PMPs released by A23187-stimulated platelets increased significantly (P <0.001), the number of PMPs released from thrombin receptor-activating peptide-stimulated platelets remained constant (P >0.05). Ex vivo, numbers of circulating PMPs were comparable in all groups. Compared with young persons, P-selectin-exposing PMPs were increased in older persons (P = 0.02) and were further increased in patients with NSTEMI (P = 0.007) and STEMI (P = 0.045). CD63-exposing PMPs were increased in patients with peripheral arterial disease (P = 0.041), NSTEMI (P = 0.001), and STEMI (P = 0.049). Subpopulations exposing P-selectin or CD63 correlated with each other (r = 0.581; P <0.001), but neither correlated with the plasma concentrations of F(1 + 2) or thrombin-antithrombin complexes. The PMP-associated fraction of sP-selectin constituted only 2.2 (4.7)% [mean (SD)] of total sP-selectin. CONCLUSIONS: PMP subpopulations reflect platelet activation status better than the total number of PMPs. Increased concentrations of circulating PMP subpopulations are found in aging, and further increases are encountered in peripheral arterial disease and myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Zee et al. (2006) conducted an observational in Peripheral arterial disease and myocardial infarction (n=61). Peripheral arterial disease and myocardial infarction vs. Healthy individuals was evaluated on Levels of P-selectin- and CD63-exposing platelet microparticles. Compared with young persons, P-selectin-exposing platelet microparticles were increased in older persons (P=0.02) and further increased in patients with NSTEMI (P=0.007) and STEMI (P=0.045).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: